Cassava Sciences Inc (SAVA)
25.75
-0.46
(-1.76%)
USD |
NASDAQ |
Nov 04, 13:04
Cassava Sciences Market Cap: 1.235B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.257B |
| October 31, 2024 | 1.238B |
| October 30, 2024 | 1.247B |
| October 29, 2024 | 1.272B |
| October 28, 2024 | 1.282B |
| October 25, 2024 | 1.274B |
| October 24, 2024 | 1.309B |
| October 23, 2024 | 1.343B |
| October 22, 2024 | 1.364B |
| October 21, 2024 | 1.386B |
| October 18, 2024 | 1.391B |
| October 17, 2024 | 1.419B |
| October 16, 2024 | 1.422B |
| October 15, 2024 | 1.356B |
| October 14, 2024 | 1.319B |
| October 11, 2024 | 1.238B |
| October 10, 2024 | 1.193B |
| October 09, 2024 | 1.199B |
| October 08, 2024 | 1.250B |
| October 07, 2024 | 1.219B |
| October 04, 2024 | 1.299B |
| October 03, 2024 | 1.293B |
| October 02, 2024 | 1.292B |
| October 01, 2024 | 1.316B |
| September 30, 2024 | 1.412B |
| Date | Value |
|---|---|
| September 27, 2024 | 1.367B |
| September 26, 2024 | 1.529B |
| September 25, 2024 | 1.462B |
| September 24, 2024 | 1.419B |
| September 23, 2024 | 1.296B |
| September 20, 2024 | 1.429B |
| September 19, 2024 | 1.457B |
| September 18, 2024 | 1.455B |
| September 17, 2024 | 1.502B |
| September 16, 2024 | 1.360B |
| September 13, 2024 | 1.349B |
| September 12, 2024 | 1.355B |
| September 11, 2024 | 1.311B |
| September 10, 2024 | 1.295B |
| September 09, 2024 | 1.292B |
| September 06, 2024 | 1.291B |
| September 05, 2024 | 1.413B |
| September 04, 2024 | 1.424B |
| September 03, 2024 | 1.342B |
| August 30, 2024 | 1.377B |
| August 29, 2024 | 1.368B |
| August 28, 2024 | 1.281B |
| August 27, 2024 | 1.382B |
| August 26, 2024 | 1.428B |
| August 23, 2024 | 1.485B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
21.33M
Minimum
Nov 18 2019
5.414B
Maximum
Jul 28 2021
1.122B
Average
1.009B
Median
Jun 04 2024
Market Cap Benchmarks
| Bristol-Myers Squibb Co | 112.08B |
| Eli Lilly and Co | 767.47B |
| Seelos Therapeutics Inc | 0.4840M |
| Biomarin Pharmaceutical Inc | 12.57B |
| EyePoint Pharmaceuticals Inc | 627.77M |
Market Cap Related Metrics
| PS Ratio | 27.32 |
| Price to Book Value | 6.537 |
| Price | 25.75 |
| Earnings Yield | -5.48% |
| Operating PE Ratio | 35.81 |
| Normalized PE Ratio | 5.410 |